Area of research
Cancer Research · Oncology
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Cancer Cells and Metastasis, and Cancer, Hypoxia, and Metabolism.
Clinical features of abdominal migraine: a systematic review and summary of data from 662 patients
NRT1.1B acts as an abscisic acid receptor in integrating compound environmental cues for plants
Biomimetic Extracellular Vesicles Containing Biominerals for Targeted Osteoporosis Therapy
Dose and local efficacy analysis of iodine-125 seed implantation therapy for lung tumors
Effects of rhEPO-Fc on chronic renal anemia in Chinese patients undergoing maintenance hemodialysis: a multicenter, randomized, open-label, and phase 3 study
Advanced glycation end products mediate biomineralization disorder in diabetic bone disease
CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1
Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity: "Single" vision for "heterogeneous" environment.
Dose and local efficacy analysis of iodine-125 seed implantation therapy for lung tumors
CT-guided iodine-125 brachytherapy as salvage therapy for local-regional recurrent breast cancer
Stat3 Signaling Pathway: A Future Therapeutic Target for Bone-Related Diseases.
Effect of Anti-Rheumatic Drugs on Cardiovascular Disease Events in Rheumatoid Arthritis
Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles.
Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer.
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway.
Eudragit S100 prepared pH-responsive liposomes-loaded betulinic acid against colorectal cancer <i>in vitro</i> and <i>in vivo</i>
The Anti-Tumor Effect and Mechanism of Triterpenoids in <i>Rhus chinensis</i> Mill. on Reversing Effector CD8+ T-cells Dysfunction by Targeting Glycolysis Pathways in Colorectal Cancer
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signaling pathway
β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer.
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-κB/MDR1 pathway in colorectal cancer.
The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer
Effects and mechanisms of fatty acid metabolism‑mediated glycolysis regulated by betulinic acid‑loaded nanoliposomes in colorectal cancer
cRGD-Conjugated Fe<sub>3</sub>O<sub>4</sub>@PDA-DOX Multifunctional Nanocomposites for MRI and Antitumor Chemo-Photothermal Therapy.
Triterpenoids Extracted from<i>Rhus chinensis Mill</i>Act Against Colorectal Cancer by Inhibiting Enzymes in Glycolysis and Glutaminolysis: Network Analysis and Experimental Validation
SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.
New strategies for targeting glucose metabolism–mediated acidosis for colorectal cancer therapy
Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction
MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling
miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma